scorecardresearchGland Pharma Share Price Live NSE, BSE, Today - Gland Pharma Stock Price

Gland Pharma

BSE: 543245 | NSE: GLAND | ISIN: INE068V01023 | SECTOR: Biotechnology & Drugs

1,798.65 4.00 (0.22%)

04 Mar 2024, 06:22 (IST)
  • Open

    1,796.25
  • High

    1,818.00
  • Low

    1,792.95
  • Prev Close

    1,794.65
  • P/E

    -
  • Median P/E

    -
  • P/B

    -
  • Median P/B

    -
  • Market Cap

    296.25B
  • Volume

    2.46K
  • Vol. (20 day Avg.)

    0
  • PEG

    -
  • Div.Yield

    -
  • Bid

    1,798.60
  • Ask

    1,801.95

Company Description

  • Biotechnology & Drugs
  • BSE

    543245
  • NSE

    GLAND
  • ISIN

    INE068V01023

Gland Pharma Limited is an India-based generic injectables manufacturer. The Company specializes in sterile injectables, oncology, and ophthalmic, with a specific focus on complex injectables, NCE-1s (New Chemical Entities), First-to-File products, and 505(b)(2) filings. The Company functions primarily on a business-to-business (B2B) model and has a record in pharmaceutical research and development, manufacturing, and marketing of complex injectables. The Company offers a range of delivery systems, including liquid vials, lyophilized vials, pre-filled syringes, ampoules, bags, and drops. It is also in the process of including new delivery systems such as pens and cartridges into its product portfolio. Its key molecules include Heparin Sodium Injection, Enoxaparin Sodium Injection, Rocuronium Bromide Injection, Daptomycin Injection, among others. Its therapeutic products categories include Anti Malarials, Anti-Infectives, Anti-Neoplastics, Gynaecological, Hormones, and others.

Company Officers

  • Srinivasa Sadu

    Chief Executive Officer, Managing Director, Whole-Time Director
  • Ravi Mitra

    Chief Financial Officer
  • Prakash Baliga

    Chief Operating Officer
  • P. Sampath Kumar

    Compliance Officer, Company Secretary
  • Ankit Gupta

    Vice President- Strategy and Investments